doi.org/10.3109/10428194.2012.728702, hdl.handle.net/1765/53920
Leukemia and Lymphoma
Erasmus School of Social and Behavioural Sciences

Abouyahya, I., Alhan, C., Westers, T., te Boekhorst, P., Kappers-Klunne, M., Coenen, J., Heyning, F., Huls, G., de Wolf, J., Imholz, B., Koene, H., Veth, G., de Kruijf, E.-J. F., Muus, P., Planken, E., Segeren, C., Vasmel, W., van der Velden, A. M. T., Velders, F., … van de Loosdrecht, A. (2013). Treatment with lenalidomide in myelodysplastic syndromes with deletion 5q: Results from the Dutch named patient program. Leukemia and Lymphoma, 54(4), 874–877.https://doi.org/10.3109/10428194.2012.728702